CervoMed CRVO
NASDAQ CRVO
$1.37 -0.06 (-4.20%)
At close: Nov 10, 2026 · 4:00 PM EST

CervoMed (CRVO) Gross Margin (2011 - 2013)

Updated

CervoMed's Gross Margin was 100.00% in Q2 2013, up 0.59 percentage points from 99.41% a year earlier.

Analysis

CervoMed (CRVO) Gross Margin (2011 - 2013) Analysis & Trends

For FY2012, Gross Margin at CervoMed came in at 37.04%, up 341.72 percentage points from FY2011.

  • In earlier years, Gross Margin was -304.68% in FY2011 (+118.83 pp) and -423.51% in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 68.12%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 75.38%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 72.95%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.03%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 73.10%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 81.07%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 75.71%
10 CervoMed 20.73 Mn -57.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 100.00%
Sep 30, 2012 99.41%
Jun 30, 2012 99.41%
Mar 31, 2012 -43.22%
Dec 31, 2011 -541.57%
Sep 30, 2011 -1.44%
API Access

CervoMed Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEY